Group One Trading, L.P. Pulse Biosciences, Inc. Transaction History

Group One Trading, L.P.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$7.8 - $11.02 $14,071 - $19,880	-1,804 Reduced 13.8%	11,271 $98,000
Q4 2023 Feb 14, 2024	BUY	$3.85 - $12.84 $43,235 - $144,193	11,230 Added 608.67%	13,075 $160,000
Q3 2023 Nov 09, 2023	BUY	$4.03 - $8.73 $7,435 - $16,106	1,845 New	1,845 $7,000
Q3 2022 Nov 09, 2022	BUY	$1.23 - $2.3 $3,372 - $6,306	2,742 New	2,742 $6,000
Q2 2022 Aug 11, 2022	SELL	$1.48 - $4.28 $978 - $2,829	-661 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$4.21 - $14.79 $2,782 - $9,776	661 New	661 $3,000
Q3 2020 Nov 12, 2020	SELL	$9.27 - $13.14 $6,349 - $9,000	-685 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$6.23 - $13.09 $722 - $1,518	116 Added 20.39%	685 $7,000
Q2 2019 Aug 09, 2019	SELL	$11.11 - $17.34 $11,110 - $17,340	-1,000 Reduced 63.73%	569 $8,000
Q1 2019 May 13, 2019	BUY	$11.69 - $19.44 $8,077 - $13,433	691 Added 78.7%	1,569 $28,000
Q4 2018 Feb 06, 2019	BUY	$9.08 - $14.34 $4,540 - $7,170	500 Added 132.28%	878 $10,000
Q3 2018 Nov 08, 2018	BUY	$12.83 - $16.45 $4,849 - $6,218	378 New	378 $5,000

4.8M

138K

96.2K

Ticker PLSE
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 37,125,900
Market Cap $541M
Description
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.